 Holly Wyatt
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weight Loss | 46 | 2023 | 655 | 4.860 |
Why?
| | Obesity | 60 | 2023 | 2746 | 3.810 |
Why?
| | Exercise | 22 | 2022 | 1657 | 1.700 |
Why?
| | Overweight | 14 | 2021 | 502 | 1.640 |
Why?
| | Motor Activity | 13 | 2014 | 660 | 1.500 |
Why?
| | Energy Intake | 16 | 2023 | 447 | 1.260 |
Why?
| | Diet, Fat-Restricted | 12 | 2018 | 76 | 1.260 |
Why?
| | Diet, Carbohydrate-Restricted | 8 | 2018 | 31 | 1.090 |
Why?
| | Behavior Therapy | 6 | 2019 | 237 | 0.980 |
Why?
| | Health Promotion | 7 | 2013 | 691 | 0.960 |
Why?
| | Body Weight | 10 | 2019 | 934 | 0.900 |
Why?
| | Weight Gain | 17 | 2013 | 493 | 0.860 |
Why?
| | Energy Metabolism | 11 | 2019 | 767 | 0.780 |
Why?
| | Health Behavior | 9 | 2018 | 720 | 0.770 |
Why?
| | Life Style | 14 | 2023 | 430 | 0.760 |
Why?
| | Monitoring, Ambulatory | 4 | 2010 | 84 | 0.700 |
Why?
| | Diet | 10 | 2023 | 1153 | 0.660 |
Why?
| | Weight Reduction Programs | 6 | 2019 | 93 | 0.660 |
Why?
| | Mental Health | 1 | 2022 | 568 | 0.570 |
Why?
| | Registries | 8 | 2022 | 1810 | 0.550 |
Why?
| | Cardiovascular Diseases | 8 | 2023 | 1798 | 0.540 |
Why?
| | Risk Reduction Behavior | 2 | 2015 | 199 | 0.540 |
Why?
| | Body Mass Index | 23 | 2018 | 2092 | 0.500 |
Why?
| | Television | 2 | 2013 | 71 | 0.490 |
Why?
| | Diet, Reducing | 7 | 2018 | 81 | 0.480 |
Why?
| | Dietary Proteins | 3 | 2023 | 130 | 0.470 |
Why?
| | Feeding Behavior | 6 | 2013 | 601 | 0.460 |
Why?
| | Survivors | 2 | 2016 | 418 | 0.450 |
Why?
| | Internet | 4 | 2023 | 633 | 0.450 |
Why?
| | Middle Aged | 45 | 2020 | 27617 | 0.440 |
Why?
| | Walking | 7 | 2011 | 415 | 0.430 |
Why?
| | Endocrinology | 1 | 2013 | 68 | 0.420 |
Why?
| | Adult | 46 | 2023 | 31512 | 0.410 |
Why?
| | Cause of Death | 1 | 2013 | 380 | 0.410 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2023 | 2174 | 0.400 |
Why?
| | Humans | 77 | 2023 | 118974 | 0.390 |
Why?
| | Thinness | 1 | 2009 | 91 | 0.340 |
Why?
| | Female | 53 | 2023 | 61565 | 0.340 |
Why?
| | Disease Outbreaks | 2 | 2009 | 322 | 0.340 |
Why?
| | Breast Neoplasms | 3 | 2016 | 1965 | 0.340 |
Why?
| | Male | 52 | 2020 | 57801 | 0.330 |
Why?
| | Dietary Fats | 5 | 2013 | 322 | 0.320 |
Why?
| | Dairy Products | 1 | 2008 | 31 | 0.310 |
Why?
| | Community Participation | 1 | 2008 | 120 | 0.290 |
Why?
| | Anti-Obesity Agents | 3 | 2013 | 49 | 0.280 |
Why?
| | Beverages | 3 | 2015 | 70 | 0.270 |
Why?
| | Non-Nutritive Sweeteners | 2 | 2015 | 5 | 0.260 |
Why?
| | Dietetics | 1 | 2005 | 22 | 0.260 |
Why?
| | Basal Metabolism | 2 | 2018 | 50 | 0.250 |
Why?
| | Hormones | 2 | 2009 | 135 | 0.250 |
Why?
| | Kidney | 1 | 2012 | 1353 | 0.250 |
Why?
| | Exercise Therapy | 3 | 2012 | 355 | 0.240 |
Why?
| | Appetite Depressants | 1 | 2004 | 21 | 0.240 |
Why?
| | United States | 16 | 2015 | 12555 | 0.230 |
Why?
| | Primary Prevention | 1 | 2005 | 185 | 0.230 |
Why?
| | Health Status | 4 | 2022 | 726 | 0.220 |
Why?
| | Prevalence | 10 | 2014 | 2326 | 0.220 |
Why?
| | Counseling | 3 | 2015 | 353 | 0.210 |
Why?
| | Time Factors | 8 | 2019 | 6412 | 0.210 |
Why?
| | Patient Satisfaction | 3 | 2018 | 610 | 0.210 |
Why?
| | Adiposity | 4 | 2023 | 516 | 0.210 |
Why?
| | Washington | 1 | 2022 | 141 | 0.210 |
Why?
| | DNA Repair | 1 | 2003 | 198 | 0.200 |
Why?
| | Biology | 1 | 2022 | 83 | 0.200 |
Why?
| | Telomere | 1 | 2003 | 204 | 0.190 |
Why?
| | Quality of Life | 6 | 2021 | 2366 | 0.190 |
Why?
| | Risk Factors | 13 | 2015 | 9000 | 0.190 |
Why?
| | Physical Exertion | 3 | 2011 | 222 | 0.180 |
Why?
| | Contraceptive Agents | 1 | 2020 | 57 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 1 | 2003 | 495 | 0.170 |
Why?
| | Aged | 18 | 2020 | 19657 | 0.170 |
Why?
| | Body Weight Maintenance | 1 | 2018 | 15 | 0.170 |
Why?
| | Diet, High-Protein | 1 | 2018 | 2 | 0.170 |
Why?
| | Self Report | 2 | 2013 | 699 | 0.160 |
Why?
| | Rest | 1 | 2018 | 104 | 0.160 |
Why?
| | Histones | 1 | 2003 | 552 | 0.160 |
Why?
| | Meat | 1 | 2018 | 89 | 0.150 |
Why?
| | Self-Control | 1 | 2018 | 49 | 0.150 |
Why?
| | Fasting | 1 | 2018 | 264 | 0.150 |
Why?
| | Health Surveys | 6 | 2008 | 454 | 0.150 |
Why?
| | Parent-Child Relations | 2 | 2011 | 232 | 0.150 |
Why?
| | Comorbidity | 4 | 2016 | 1527 | 0.150 |
Why?
| | Caloric Restriction | 3 | 2014 | 89 | 0.150 |
Why?
| | Adaptation, Physiological | 2 | 2018 | 502 | 0.140 |
Why?
| | Models, Psychological | 1 | 2018 | 298 | 0.140 |
Why?
| | Eating | 3 | 2013 | 369 | 0.140 |
Why?
| | Food Preferences | 2 | 2018 | 119 | 0.130 |
Why?
| | Treatment Outcome | 9 | 2015 | 9342 | 0.130 |
Why?
| | Sweetening Agents | 1 | 2014 | 52 | 0.120 |
Why?
| | Dietary Carbohydrates | 4 | 2011 | 153 | 0.120 |
Why?
| | Blood Glucose | 2 | 2023 | 1939 | 0.120 |
Why?
| | Executive Function | 1 | 2018 | 391 | 0.120 |
Why?
| | Adolescent | 13 | 2019 | 18480 | 0.120 |
Why?
| | Metabolic Syndrome | 2 | 2007 | 394 | 0.120 |
Why?
| | Recurrence | 2 | 2013 | 975 | 0.110 |
Why?
| | Bupropion | 1 | 2013 | 38 | 0.110 |
Why?
| | Drinking Water | 1 | 2014 | 68 | 0.110 |
Why?
| | Nutritional Status | 1 | 2015 | 300 | 0.110 |
Why?
| | Water | 1 | 2015 | 425 | 0.110 |
Why?
| | Accelerometry | 1 | 2013 | 72 | 0.110 |
Why?
| | Nutrition Surveys | 2 | 2014 | 233 | 0.110 |
Why?
| | Endothelium | 1 | 2013 | 120 | 0.110 |
Why?
| | Naltrexone | 1 | 2013 | 80 | 0.110 |
Why?
| | Primary Health Care | 1 | 2002 | 1560 | 0.110 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 66 | 0.110 |
Why?
| | Insulin | 3 | 2018 | 2162 | 0.100 |
Why?
| | Kidney Function Tests | 1 | 2012 | 164 | 0.100 |
Why?
| | Appetite Regulation | 1 | 2011 | 26 | 0.100 |
Why?
| | Appetite | 1 | 2011 | 57 | 0.100 |
Why?
| | Epidemics | 1 | 2011 | 70 | 0.100 |
Why?
| | Body Composition | 3 | 2023 | 653 | 0.090 |
Why?
| | Bariatric Surgery | 1 | 2013 | 166 | 0.090 |
Why?
| | Young Adult | 7 | 2019 | 10793 | 0.090 |
Why?
| | Family Health | 2 | 2007 | 201 | 0.090 |
Why?
| | Nutritional Requirements | 1 | 2009 | 75 | 0.090 |
Why?
| | Adipose Tissue | 2 | 2011 | 606 | 0.090 |
Why?
| | Hypercholesterolemia | 1 | 2010 | 93 | 0.090 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2010 | 167 | 0.090 |
Why?
| | Secondary Prevention | 1 | 2010 | 227 | 0.090 |
Why?
| | Family | 1 | 2013 | 585 | 0.080 |
Why?
| | Public Health | 2 | 2011 | 450 | 0.080 |
Why?
| | Prospective Studies | 6 | 2020 | 6471 | 0.080 |
Why?
| | Aged, 80 and over | 6 | 2009 | 6561 | 0.080 |
Why?
| | Carotid Arteries | 1 | 2009 | 184 | 0.080 |
Why?
| | Socioeconomic Factors | 3 | 2011 | 1129 | 0.080 |
Why?
| | Animals | 8 | 2023 | 33381 | 0.080 |
Why?
| | Cattle | 2 | 2023 | 978 | 0.080 |
Why?
| | Lythraceae | 1 | 2007 | 2 | 0.080 |
Why?
| | Sick Leave | 1 | 2007 | 12 | 0.080 |
Why?
| | Hydrolyzable Tannins | 1 | 2007 | 9 | 0.080 |
Why?
| | New York | 1 | 2008 | 118 | 0.080 |
Why?
| | Coronary Disease | 2 | 2007 | 356 | 0.080 |
Why?
| | Child | 7 | 2013 | 19129 | 0.080 |
Why?
| | Disease Susceptibility | 1 | 2009 | 331 | 0.080 |
Why?
| | Dietary Sucrose | 1 | 2007 | 55 | 0.080 |
Why?
| | Patient Compliance | 2 | 2018 | 537 | 0.080 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 900 | 0.080 |
Why?
| | Efficiency | 1 | 2007 | 89 | 0.070 |
Why?
| | Triglycerides | 4 | 2013 | 519 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 1185 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2019 | 3171 | 0.070 |
Why?
| | Edible Grain | 1 | 2006 | 43 | 0.070 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 468 | 0.070 |
Why?
| | Neoplasms | 1 | 2020 | 2179 | 0.070 |
Why?
| | Interviews as Topic | 2 | 2007 | 599 | 0.070 |
Why?
| | Regression Analysis | 2 | 2007 | 983 | 0.070 |
Why?
| | Coronary Artery Bypass | 1 | 2007 | 209 | 0.070 |
Why?
| | Metabolic Diseases | 1 | 2007 | 103 | 0.070 |
Why?
| | Patient Education as Topic | 2 | 2007 | 699 | 0.070 |
Why?
| | Cost of Illness | 1 | 2007 | 258 | 0.070 |
Why?
| | Physical Fitness | 1 | 2007 | 179 | 0.070 |
Why?
| | Calorimetry, Indirect | 2 | 2018 | 72 | 0.070 |
Why?
| | Marital Status | 1 | 2005 | 43 | 0.060 |
Why?
| | Social Support | 1 | 2009 | 542 | 0.060 |
Why?
| | Analysis of Variance | 4 | 2011 | 1293 | 0.060 |
Why?
| | Heart Ventricles | 1 | 2009 | 727 | 0.060 |
Why?
| | Colorado | 4 | 2007 | 4196 | 0.060 |
Why?
| | Computer Simulation | 1 | 2009 | 922 | 0.060 |
Why?
| | Rural Population | 1 | 2008 | 452 | 0.060 |
Why?
| | Health Care Costs | 1 | 2007 | 394 | 0.060 |
Why?
| | Cyclobutanes | 1 | 2004 | 7 | 0.060 |
Why?
| | Patient Participation | 1 | 2007 | 369 | 0.060 |
Why?
| | Rats, Wistar | 3 | 2011 | 399 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2007 | 467 | 0.060 |
Why?
| | Blood Pressure | 3 | 2019 | 1664 | 0.060 |
Why?
| | Lactones | 1 | 2004 | 57 | 0.060 |
Why?
| | Diabetes Complications | 1 | 2005 | 218 | 0.060 |
Why?
| | Program Evaluation | 1 | 2007 | 845 | 0.060 |
Why?
| | Lipoproteins | 3 | 2010 | 162 | 0.060 |
Why?
| | Diabetic Angiopathies | 1 | 2005 | 260 | 0.060 |
Why?
| | Body Constitution | 1 | 2002 | 47 | 0.060 |
Why?
| | Acetylation | 1 | 2003 | 217 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 827 | 0.050 |
Why?
| | Leisure Activities | 1 | 2002 | 27 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2007 | 1244 | 0.050 |
Why?
| | Educational Status | 3 | 2012 | 437 | 0.050 |
Why?
| | Bleomycin | 1 | 2003 | 228 | 0.050 |
Why?
| | DNA Damage | 1 | 2003 | 357 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 103 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2018 | 4596 | 0.050 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 39 | 0.040 |
Why?
| | Telemedicine | 1 | 2007 | 664 | 0.040 |
Why?
| | Parents | 1 | 2007 | 1212 | 0.040 |
Why?
| | Cross-Sectional Studies | 4 | 2014 | 4552 | 0.040 |
Why?
| | Child, Preschool | 2 | 2011 | 9491 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2002 | 482 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 24 | 0.040 |
Why?
| | Phosphorylation | 1 | 2003 | 1633 | 0.040 |
Why?
| | Portion Size | 1 | 2018 | 7 | 0.040 |
Why?
| | Thermogenesis | 1 | 2018 | 43 | 0.040 |
Why?
| | Cluster Analysis | 2 | 2012 | 481 | 0.040 |
Why?
| | Motivation | 1 | 2002 | 506 | 0.040 |
Why?
| | Leptin | 2 | 2013 | 231 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2019 | 149 | 0.040 |
Why?
| | Craving | 1 | 2018 | 33 | 0.040 |
Why?
| | Hunger | 1 | 2018 | 46 | 0.040 |
Why?
| | Patient Dropouts | 1 | 2018 | 66 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 554 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 2995 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2513 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 1200 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2005 | 942 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1166 | 0.040 |
Why?
| | Rats | 3 | 2011 | 5392 | 0.030 |
Why?
| | Models, Biological | 2 | 2018 | 1715 | 0.030 |
Why?
| | Lipid Metabolism | 2 | 2011 | 477 | 0.030 |
Why?
| | Precision Medicine | 1 | 2018 | 363 | 0.030 |
Why?
| | Circadian Rhythm | 2 | 2009 | 401 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1868 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2013 | 53 | 0.030 |
Why?
| | Nausea | 1 | 2013 | 107 | 0.030 |
Why?
| | Waist Circumference | 1 | 2013 | 130 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2013 | 161 | 0.030 |
Why?
| | Psychotherapy, Group | 1 | 2012 | 61 | 0.030 |
Why?
| | Narcotic Antagonists | 1 | 2013 | 136 | 0.030 |
Why?
| | Brachial Artery | 1 | 2013 | 181 | 0.030 |
Why?
| | Hypertension | 2 | 2013 | 1203 | 0.030 |
Why?
| | Dyslipidemias | 1 | 2013 | 162 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 649 | 0.020 |
Why?
| | Switzerland | 1 | 2010 | 27 | 0.020 |
Why?
| | Ketone Bodies | 1 | 2010 | 17 | 0.020 |
Why?
| | Japan | 1 | 2010 | 97 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2011 | 3730 | 0.020 |
Why?
| | Behavior, Addictive | 1 | 2011 | 77 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 965 | 0.020 |
Why?
| | Tunica Media | 1 | 2009 | 36 | 0.020 |
Why?
| | Australia | 1 | 2010 | 212 | 0.020 |
Why?
| | Social Environment | 1 | 2011 | 294 | 0.020 |
Why?
| | Tunica Intima | 1 | 2009 | 78 | 0.020 |
Why?
| | Vasodilation | 1 | 2013 | 457 | 0.020 |
Why?
| | Diastole | 1 | 2009 | 145 | 0.020 |
Why?
| | Systole | 1 | 2009 | 168 | 0.020 |
Why?
| | Socioenvironmental Therapy | 1 | 2009 | 1 | 0.020 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2009 | 107 | 0.020 |
Why?
| | Photoperiod | 1 | 2009 | 55 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2009 | 198 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 1687 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2013 | 709 | 0.020 |
Why?
| | Attitude to Health | 1 | 2012 | 410 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 3588 | 0.020 |
Why?
| | Satiety Response | 1 | 2008 | 8 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 940 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2010 | 316 | 0.020 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2007 | 22 | 0.020 |
Why?
| | Consumer Product Safety | 1 | 2007 | 31 | 0.020 |
Why?
| | Polyphenols | 1 | 2007 | 17 | 0.020 |
Why?
| | Adipocytes | 1 | 2009 | 199 | 0.020 |
Why?
| | Ventricular Remodeling | 1 | 2009 | 229 | 0.020 |
Why?
| | Flavonoids | 1 | 2007 | 71 | 0.020 |
Why?
| | Echocardiography | 1 | 2009 | 556 | 0.020 |
Why?
| | Phenols | 1 | 2007 | 85 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2007 | 128 | 0.020 |
Why?
| | Bone Density | 1 | 2010 | 449 | 0.020 |
Why?
| | Exercise Test | 1 | 2009 | 551 | 0.020 |
Why?
| | Demography | 1 | 2007 | 274 | 0.020 |
Why?
| | Employment | 1 | 2007 | 135 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2008 | 456 | 0.020 |
Why?
| | Health Expenditures | 1 | 2007 | 174 | 0.020 |
Why?
| | Nutrition Assessment | 1 | 2006 | 78 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 50 | 0.020 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2006 | 98 | 0.020 |
Why?
| | Insurance, Health | 1 | 2007 | 244 | 0.020 |
Why?
| | Interpersonal Relations | 1 | 2009 | 345 | 0.020 |
Why?
| | Homeostasis | 1 | 2009 | 594 | 0.020 |
Why?
| | Sex Factors | 1 | 2011 | 1781 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1474 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 564 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 2874 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1945 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 12978 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1515 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2445 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 4708 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 938 | 0.010 |
Why?
| | Pediatrics | 1 | 2007 | 985 | 0.010 |
Why?
| | Glucose | 1 | 2003 | 953 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2007 | 2235 | 0.010 |
Why?
|
|
Wyatt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|